ReviewPostepy psychiatrii neurologii2026
The role of adipokines in the inflammatory theory of depression: mechanisms and therapeutic applications.
Review in Postepy psychiatrii neurologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To demonstrate the link between excessive fat tissue and depression. To discuss the role of adipokines as a bridge connecting increased fat tissue with inflammatory processes which influence the development of depression. Views: Disruptions in the activity of adipokines, molecules secreted by adipose tissue, can significantly influence inflammatory responses by modulating the production and balance of both pro-inflammatory and anti-inflammatory cytokines produced by immune cells. According to the inflammatory theory of depression, it is the chronic dysregulation of the Th1/Th2 immune response ratio, along with persistent low-grade inflammation, that together contribute to the development and persistence of depressive symptoms. Therefore, excessive amounts of adipose tissue and elevated adipokine secretion in patients appear to substantially increase the likelihood of depression. Conclusions: Research shows that elevated levels of pro-inflammatory adipokines, such as leptin and resistin, may be associated with depression by intensifying inflammatory processes in the brain and disrupting neurotransmitter balance. In contrast, adiponectin - a protein with anti-inflammatory properties - has a different effect. Determining the relationship between the amount of body fat in patients and depression may be useful for predicting and monitoring the progression of depression in individuals with excessive body weight. Early identification of depression risk in this group could enable timely medical intervention and treatment, potentially reducing dangerous behaviors and improving therapeutic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.